NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/30/2023
Back to search
Official data from USPTO
B'LANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
05/30/2023
Trademark type
Combined
Nice classes
5
Filing date
01/27/2021
Registration date
05/30/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/30/2023
Last transaction
05/30/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
16
Owner location
Berlin, DE
Examiner
DIXON, JENNIFER
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "B'LANCE" with an incomplete circle behind the letters "LANC".
Holders and representatives
Holders
VIVANT BIOTECHNOLOGY GmbH
Representatives
HUI ZHANG RABIN & BERDO, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Amino acids for medical purposes; Amino acids for veterinary purposes; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical purposes; Dietetic substances adapted for medical use; Medicinal drinks; Medicinal infusions for rehydrationnutritionthe delivery of pharmaceutical preparations to prevent and for the treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressserotonin deficiency syndromeneurotransmitter imbalance and long covid; Medicines for human purposes for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and/or drug intoxications and hangovermuscle fatigue after excessive physical stressSerotonin deficiency Syndromeneurotransmitter imbalance and long covid; Pharmaceutical preparations for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressserotonin deficiency syndromeneurotransmitter imbalance and long covid; Pharmaceuticals for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressSerotonin deficiency Syndromeneurotransmitter imbalance and long covid; Pre-filled Syringes sold filled with hyaluronic acidpharmaceuticals and supplementsall containing vitaminsamino acidsproteinscreatineelectrolytestrace elementscoenzymesvital nutrientscarbohydrates; Medicated serums for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressserotonin deficiency Syndromeneurotransmitter imbalance and long covid; Sodium salts for medical purposes; Vitamin preparations; Medicinal infusionsintravenous fluids used for rehydrationnutrition and the delivery of pharmaceutical preparations; Pharmaceuticals and natural remedy preparations for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressSerotonin deficiency Syndromeneurotransmitter imbalance and long covid; Medicines for human purposesintravenous bags sold filled with intravenous fluids used for rehydrationnutritionthe delivery of pharmaceutical preparations for humans; Medicinal infusionsintravenous fluids used for rehydrationnutritionthe delivery of pharmaceutical preparations for humans
Publications
History of USPTO decisions and trademark events.
39 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2023
CNEA
EXAMINERS AMENDMENT MAILED
02/08/2023
OTHE
CASE RETURNED TO EXAMINATION
02/08/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/08/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
02/01/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
02/01/2023
APET
ASSIGNED TO PETITION STAFF
01/30/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
01/10/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/08/2022
TMBN
TTAB RELEASE CASE TO TRADEMARKS
09/29/2022
OP.T
OPPOSITION TERMINATED NO. 999999
09/29/2022
OP.D
OPPOSITION DISMISSED NO. 999999
09/29/2022
OP.I
OPPOSITION INSTITUTED NO. 999999
06/28/2022
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
06/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/31/2022
PUBO
PUBLISHED FOR OPPOSITION
05/31/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/11/2022
ALIE
ASSIGNED TO LIE
04/25/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/28/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/28/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/15/2021
GNFR
FINAL REFUSAL E-MAILED
12/15/2021
CNFR
FINAL REFUSAL WRITTEN
12/15/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/15/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/01/2021
GNRT
NON-FINAL ACTION E-MAILED
09/01/2021
CNRT
NON-FINAL ACTION WRITTEN
09/01/2021
DOCK
ASSIGNED TO EXAMINER
08/14/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2021
NWAP
NEW APPLICATION ENTERED
01/30/2021
Continuous trademark protection
Get notified about every new filing that threatens B'LANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.